名稱 | NALM6/ADR |
型號(hào) | CBP61298DR |
報(bào)價(jià) | ![]() |
特點(diǎn) | NALM6/ADR |
產(chǎn)品搜索
相關(guān)文章
- ATCC細(xì)胞株培養(yǎng)操作
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- Western Blot標(biāo)準(zhǔn)操作流程
- 細(xì)胞株購買為何比較看重生物等級(jí)?
- 5月是黑色素瘤意識(shí)月,盤點(diǎn)黑色素瘤研究進(jìn)展
- 攝入全谷類食物能明顯降低患結(jié)直腸癌的風(fēng)險(xiǎn)
- 泛腫瘤大panel質(zhì)控品升級(jí),免費(fèi)試用申請(qǐng)中
- OSMR細(xì)胞篩選模型
- 特應(yīng)性皮炎(AD)賽道新治療——OX40靶點(diǎn)
- 【新品上線】多重病原菌質(zhì)控品
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS

- 詳細(xì)內(nèi)容
CBP61298DR | |
I. Introduction | |
Host Cell: | NALM6/ADR |
Description:: | NALM6/ADR cells, are an Adriamycin (doxorubicin)-selected, P-gp-positive (P-glycoprotein 1) variant of the NALM6 cell line. |
Culture Medium: | 1640+10%FBS+70nM Doxorubicin |
Gi50 on NALM6/Doxorubicin: | N/A |
Gi50 on NALM6: | N/A |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen |
II. Description of Host Cell Line | |
Organism: | Human |
Tissue: | Peripheral blood |
Disease: | Acute lymphoblastic leukemia ALL |
Morphology: | Lymphocyte-like |
Growth Properties: | N/A |
" _ue_custom_node_="true">